Latest filing published 07 Feb 2024 for 4D Molecular Therapeutics, Inc., €208k.
Filing timeline
BuySaleInsider track record
Robert Young Kim: trading record in brief
Robert Young Kim is a declared insider of 4D Molecular Therapeutics, Inc., with filings sourced from SEC (Form 4). Activity is concentrated on a single trading day, 5 February 2024, with 7 filings.
The open-market record consists of 4 sales worth €684k, with no purchase. The rest of the record consists of 3 option exercises.
On 7 February 2024 came the latest disclosure, an option exercise for €208k in 4D Molecular Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert Young Kim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,000 shares@ US$18.66100.0% of flowCommon StockSEC:0000950170-24-012456:0
- 12,000 shares@ US$30.0539.0% of flowCommon StockSEC:0000950170-24-012456:1
- 6,000 shares@ US$15.7810.2% of flowCommon StockSEC:0000950170-24-012456:2
- 6,000 shares@ US$30.0519.5% of flowCommon StockSEC:0000950170-24-012456:3
- 6,000 shares@ US$8.045.2% of flowCommon StockSEC:0000950170-24-012456:4
- 552 shares@ US$30.051.8% of flowCommon StockSEC:0000950170-24-012456:6
6 of 6 declarations
